Catheter-Related Infections

Approved for this indication (1)

• taurolidine

Phase 4 trials (19)

• sodium citrate
• heparin
• linezolid
• ethanol
• tigecycline
• daptomycin
• iodine
• octenidine
• lidocaine
• teicoplanin
• vancomycin
• propanolol
• gentamicin
• isopropyl alcohol
• apixaban
• sodium bicarbonate
• nitrofurantoin
• sodium chloride
• chlorhexidine

Phase 3 trials (9)

• acetylcysteine
• cefazolin
• mupirocin
• dalbavancin
• enoxaparin
• minocycline
• bacitracin
• neomycin
• citric acid

Phase 2 trials (3)

• nitroglycerin
• vitamin c
• alteplase

Phase 1 trials (1)

• micafungin

Other trials (5)

• hexamethylenetetramine
• ciprofloxacin
• escherichia coli nissle 1917
• trimethoprim
• hydrogen peroxide

Organization Involved with Phase 4 Indications (7)

• Catholic University of Pelotas
• Federal University of Rio Grande do Sul
• Oakland University
• University of Toronto
• University of Bern
• University of Freiburg
• Clinica Universidad de Navarra

Organization Involved with Phase 3 Indications (10)

• PPD
• CorMedix
• Leonard-Meron Biosciences, Inc.
• University of Zagreb
• Davita Clinical Research
• Instituto de Medicina Integral Professor Fernando Figueira
• GuardianMed j.d.o.o. Research and development in medicine
• JMI Laboratories
• Spectra Clinical Research
• Frenova Renal Research

Organization Involved with Phase 2 Indications (5)

• Novel Anti-Infective Technologies, LLC
• Harvard University
• University of Colorado, Denver
• University of Texas at Houston
• The University of Texas, Dallas

Organization Involved with Phase 1 Indications (1)

• Baylor University

Organization Involved with Other Experimental Indications (11)

• National Cancer Institute (NCI)
• Winnipeg Regional Health Authority
• The Methodist Hospital System
• University of Pennsylvania
• University of Manitoba
• University of Pittsburgh
• Hôpital Raymond Poincaré
• Hospital General Universitario Gregorio Marañon
• East Carolina University
• Methodist Cancer Center, Houston, Texas
• MED XL Inc